HYPR
Medical Devices · Healthcare
CFO
2023-02-13–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Hyperfine, Inc. publishes a filing, an earnings call transcript or a press release.
Get HYPR alertsBrett Hale is recorded as CFO at Hyperfine, Inc. (HYPR). The newest filing on record that lists Brett Hale as CFO at Hyperfine, Inc. (HYPR) is dated April 8, 2026. Hyperfine, Inc. reported in an 8-K filed February 8, 2023 that Brett Hale was appointed Chief Administrative Officer, effective February 13, 2023. The proxy statement of Hyperfine, Inc. reports total compensation of $799,634 for Brett Hale in fiscal 2025, including a base salary of $449,815. Disclosed compensation is on record for 3 fiscal years. Brett Hale has spoken on 15 earnings calls across 1 company, most recently for Hyperfine, Inc. on August 6, 2026. Hyperfine, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Hyperfine, Inc. includes Art Cohen (CEO and Board Member), Dave Scott (CEO), Maria Sainz (CEO and Board Member) and 7 others.
“On February 8, 2023, Hyperfine, Inc. (the “Company”) announced that Brett Hale has been appointed by the Board of Directors of the Company (the “Board”) to serve as Chief Administrative Officer of the Company, effective as of February 13, 2023 (the “Appointment Date”), and Chief Financial Officer of the Company, effective as of the date immediately following the date (the “2022 Form 10-K Filing Date”) the Company files its Annual Report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (the “SEC”).”
“I'll recap our financial results for the second quarter of 2026 before providing an update on our guidance.”
“I will recap our financial results for the first quarter of 2026 before providing an update on our guidance. Revenue for the first quarter of 2026 was $3.9 million compared to $2.1 million in the first quarter of 2025, representing an increase of $1.8 million or 83% year-over-year.”
“Before I recap our financial results for the fourth quarter and full year of 2025 and our expectations for 2026, I want to touch on our recently strengthened capital position.”
“I will recap our financial results for 2025 before providing an update on our financial guidance. Revenue for 2025 was $3.4 million, up 27% sequentially. In 2025, we sold eight units, had a strong mix of next-generation subsystem sales, and delivered a record average selling price.”
“I will recap our financial results for the second quarter of 2025 before providing an update on our financial guidance. Revenue for the second quarter of 2025 was $2.7 million, up 26% sequentially.”
SEC 8-K
2023-02-13–present
Start not stated–present
Last confirmed April 8, 2026
HYPR
Medical Devices · Healthcare
CFO
2023-02-13–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Hyperfine, Inc. (HYPR) | Chief Administrative Officer and Chief Financial Officer | $449,815 | $799,634 |
| 2024 | Hyperfine, Inc. (HYPR) | Chief Administrative Officer and Chief Financial Officer | $438,846 | $1,053,316 |
| 2023 | Hyperfine, Inc. (HYPR) | Chief Administrative Officer and Chief Financial Officer | $367,788 | $1,810,267 |